Detecting Potential Formulation Roadblocks in Early Drug Development
Pharmaceutical Technology will host a panel discussion focused on early drug development on April 24, 2018 at CPhI North America.
Pharmaceutical Technology will host a panel discussion,Detecting Potential Formulation Roadblocks in Early Drug Development, on April 24, 2018 at CPhI North America in Philadelphia, PA.
In the discussion, moderated by Rita Peters, editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International, a panel of experts will explore tools, strategies, and methods for assessing the formulation, drug delivery, and manufacturing potential of a drug candidate in preclinical phases. Implications for timelines, API materials, and budgets will also be discussed.
Panelist include Stephen Tindal, director of Science Affairs at Catalent Pharma Solutions, and Ronald D. Snee, PhD, founder and president at Snee Associates, a consultancy that provides guidance for improved business performance using data-based improvement approaches such as lean six sigma and quality by design.
For more information and to register for the event, visit www.cphinorthamerica.com.
Source: CPhI North America
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
